POEMS Syndrome Demonstrating VEGF Decrease by Ticlopidine
Authors:
Open Access
- 1 January 2004
- journal article
- case report
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 43 (11) , 1082-1083
Abstract
POEMS syndrome is a syndrome that presents with polyneuropathy, organomegaly, endocrinopathy, M-proteins and skin changes. Elevated vascular endothelial growth factor (VEGF) has recently been reported in POEMS syndrome. We report a case of POEMS syndrome with high VEGF titers. Steroid, plasmapheresis and intravenous gamma-globulin had little effect. Various immunosuppressive agents were discontinued due to side effects. Although administration of aspirin did not decrease VEGF, ticlopidine decreased VEGF significantly. This case suggests that ticlopidine is a candidate for supportive therapy in POEMS syndrome and we should measure VEGF before and after the administration of ticlopidine in other cases.Keywords
This publication has 4 references indexed in Scilit:
- Platelets modulate gastric ulcer healing: Role of endostatin and vascular endothelial growth factor releaseProceedings of the National Academy of Sciences, 2001
- Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndromeMuscle & Nerve, 2000
- Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndromeAmerican Journal of Kidney Diseases, 1999
- Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregationProceedings of the National Academy of Sciences, 1998